MOLN — Molecular Partners AG Cashflow Statement
0.000.00%
Last trade - 00:00- CH₣133.93m
- CH₣44.52m
Annual cashflow statement for Molecular Partners AG, fiscal year end - December 31st, CHF millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -63.8 | 118 | -62 | -54 | -61.7 |
| Depreciation | |||||
| Non-Cash Items | 5.53 | 5 | 6.62 | -3.74 | 7.08 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -35.3 | -6.67 | -6.06 | -3.83 | 1.18 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -91 | 119 | -59 | -59.2 | -51.3 |
| Capital Expenditures | -1.31 | -1.42 | -0.808 | -0.723 | -0.714 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -20.9 | -99.7 | 45.4 | 41.2 | 73.3 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -22.2 | -101 | 44.6 | 40.5 | 72.5 |
| Financing Cash Flow Items | — | — | — | -1.74 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 50.6 | -1.57 | -1.17 | 14.4 | -1.15 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -61.9 | 16.1 | -20.6 | -3.44 | 18.8 |